ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Places Controls On Silicone Implants, Though Still Available For Reconstruction

April 25, 1992

NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas

September 12, 1986

DCT Counselors Ponder Coordination, New Opportunities

December 12, 1975

Colorado universities install huge NMR magnet. NCI to transfer 5 A Day to CDC.

May 27, 2005

Lenalidomide Maintenance Increased PFS and Survival

May 25, 2012

Special Issue: Broder Resigns NCI To Take Job With Drug Company IVAX

December 22, 1994